ACPU
BIIB icon

Arrowgrass Capital Partners (US)’s Biogen BIIB Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-67,000
Closed -$21.3M – 175
2017
Q4 		$21.3M Buy
67,000
+65,938
+6,209% +$21.2M 0.21% 118
2017
Q3 		$33.3M Hold
1,062
– – 0.25% 97
2017
Q2 		$28.8M Buy
1,062
+912
+608% +$241K 0.22% 120
2017
Q1 		$4.1M Sell
150
-480
-76% -$136K 0.04% 350
2016
Q4 		$17.9M Buy
630
+39
+7% +$11.6K 0.2% 111
2016
Q3 		$18.5M Sell
591
-312
-35% -$92.4K 0.25% 89
2016
Q2 		$21.8M Buy
903
+80
+10% +$21.1K 0.23% 69
2016
Q1 		$21.4M Buy
823
+473
+135% +$125K 0.26% 69
2015
Q4 		$10.7M Buy
+350
New +$101K 0.13% 101
2015
Q3 		– Sell
-210
Closed -$8.48M – 460
2015
Q2 		$8.48M Buy
210
+99
+89% +$39.7K 0.13% 152
2015
Q1 		$4.69M Sell
111
-34,689
-100% -$13.7M 0.07% 155
2014
Q4 		$11.8M Buy
+34,800
New +$11.3M 0.21% 69
2014
Q2 		– Sell
-1,700
Closed -$520K – 235
2014
Q1 		$520K Buy
+1,700
New +$540K 0.02% 151

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s BIIB Position: Q3 2017 in Review

Arrowgrass Capital Partners (US) sold out of Biogen (BIIB) in Q3 2017, closing a stake of 56,916 shares — an estimated $16.9M sold.

Arrowgrass Capital Partners (US) first reported a position in BIIB in Q2 2015 and held it in 7 quarters. The position peaked at $18.4M in Q1 2017. 1,015 funds tracked by Wall St. Rank hold BIIB as of Q3 2017.

  • Arrowgrass Capital Partners (US) reported no remaining Biogen position as of Q3 2017 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 56,916 Biogen shares in Q3 2017, an estimated $16.9M.
  • Arrowgrass Capital Partners (US) first reported a position in Biogen in Q2 2015 and held it in 7 quarters.
  • Arrowgrass Capital Partners (US)'s Biogen position peaked at $18.4M in Q1 2017.
  • 1,015 funds tracked by Wall St. Rank held Biogen as of Q3 2017.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q3 2017, filed 14 Nov 2017.